No Data
Market Might Still Lack Some Conviction On Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SZSE:300937) Even After 38% Share Price Boost
Pharma Tesco: 2024 Annual Results Forecast
Revenues Tell The Story For Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SZSE:300937) As Its Stock Soars 34%
Yiyigou (300937.SZ): plans to invest in Xinhua Chain through a capital increase and share expansion.
On November 22, Gelonghui reported that Yaoyigou (300937.SZ) announced that in order to promote cooperation in the pharmaceutical industry, jointly expand market scale, and enhance market influence, the company's wholly-owned subsidiary Sichuan Yaoyigou Technology Group Co., Ltd. (referred to as "Yaoyigou Technology") signed an "Investment Agreement on Chongqing Xinhua Pharmacy Chain Co., Ltd." with Chongqing Xinhua Pharmacy Chain Co., Ltd. (referred to as "Xinhua Chain" or "target company"), Chongqing Haihu Group Co., Ltd., Mr. Zhang Yuehong, Ms. Luo Yuqin, and Ms. Zhang Peiyue. Yaoyigou Technology plans to invest 150 million yuan of its own funds at a post-investment valuation of 0.3 billion yuan.
Weak Statutory Earnings May Not Tell The Whole Story For Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937)
Medicago: Report for the third quarter of 2024
